H.P. Acthar Gel is a hormone (adrenocorticotropic hormone – ACTH) that works by stimulating the body to produce more adrenocortical hormones (corticosteroids, glucocorticoids). It is used to treat conditions caused by allergies, breathing issues, blood or endocrine problems, arthritis, skin or eye problems, bowel inflammation, certain cancers, and multiple sclerosis (MS).

In MS specifically, H.P. Acthar Gel is used to treat adults with acute relapses. Studies have shown that the gel is effective in speeding recovery of an MS relapse, but there is no evidence that it affects the natural progression of the disease or its ultimate outcome.

H.P. Acthar has been approved by the U.S. Food and Drug Administration (FDA) for short-term treatment of acute relapses of MS.

ACTH is available for people with MS who don’t tolerate the side effects of high doses of corticosteroids, prefer self-injection, have been treated without success with cortiscosteroids, or have difficulty receiving intravenous medication.

H.P. Acthar gel is usually administered as an injection under the skin or into a muscle at a doctor’s office or at home. If it is administered at home, the injection procedures must be carefully followed. For MS relapse treatment, it is usually injected once daily for 2 to 3 weeks, and then the dose is gradually decreased.

The most common side effects of H.P. Acthar are similar to those of steroids: fluid retention, changes in blood sugar, increased blood pressure, behavior and mood changes and changes in appetite and weight.

There is currently no generic version of H.P. Acthar Gel available in the U.S.

Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

  1. https://www.drugs.com/cdi/hp-acthar-gel.html
  2. http://www.actharmsrelapse.com
  3. http://www.nationalmssociety.org/Treating-MS/Medications/H-P-Acthar®
  4. https://medlineplus.gov/druginfo/meds/a613006.html
  5. https://www.drugs.com/availability/generic-h-p-acthar-gel.html

Burden of Multiple Sclerosis Relapses Is Underappreciated, Study Says

The burden of moderate-to-severe relapses in multiple sclerosis (MS) patients is underappreciated, according to a study sponsored by the pharmaceutical company Mallinckrodt. Researchers discussed the findings at the American Academy of Neurology’s 69th annual meeting in Boston, April 22-28. The title of the presentation was “The Economic Burden Of Moderate-To-Severe Multiple Sclerosis Relapse In The United […]

Acthar Gel of Dubious Value in Treating MS Despite its $34,000-Per-Vial Cost, Study Finds

Medicare spent more $650 million in 2013 and 2014 on one single medication — H.P. Acthar Gel —— that was prescribed by fewer than 1 percent of clinicians to treat multiple sclerosis (MS), with questionable results. That’s the conclusion of new research by Oregon Health and Science University (OSHU), which presented its findings Feb. 23 at the Americas Committee for […]

H.P. Acthar Gel a Cost-Effective Option for Managing MS Relapses, Study Reports

A recent study analyzing the healthcare resource use and cost of H.P. Acthar Gel, an injectable drug used to manage multiple sclerosis (MS) relapse, demonstrated that the therapy is a viable alternative to plasmapheresis (PMP) and intravenous immunoglobin (IVIG). Annual direct healthcare costs encountered by MS patients in the U.S. are, on average, $24,000 higher than […]

Acthar Gel an Effective Treatment for MS Relapses at Lower Cost, Company Reports

Clinical results presented at the recent Academy of Managed Care Pharmacy (AMCP)‘s 2016 annual meeting in San Francisco showed that the use of H.P. Acthar Gel during multiple sclerosis (MS) relapses is associated with beneficial outcomes. The gel, according to its producer, is also available at a lower price than other frequently used drugs. H.P. Acthar Gel, manufactured by […]

MS Views & News Awards Questcor With “Recognition of Appreciation” Award Multiple Sclerosis Advocacy

Questcor Pharmaceuticals, Inc. is a drug development company with a viable Multiple Sclerosis drug called H.P. Acthar® Gel, which is currently approved in the U.S. by the FDA for the treatment of acute exacerbations of multiple sclerosis in adults. However, in addition to developing and commercializing MS therapies, the company has also gone above and […]